@GM2
Great start for the month.
Excellent findings for GTG's Covid severity test, they are trying hard to get this moving.
The news we have all been waiting for HAS NOT yet come. However, this news is very positive going forward.
Kinda sad that the manipulators aren’t even disguising the fact they can take it right back to yesterday’s closing price for GENE. Typical penny stock...
Last night GENEs high vol >2M T/O, >3x issue, people who bought in the mid 4s AH yesterday are dumping to cut their losses and Shorts are piling in once again.
- SNP array panels from US-based Thermo Fisher Scientific Inc - Should be in.!
- Sourced cross validation data (expected late September / early October) - Should be in.!
- The Company should be submitting their complete technical package with the expected 45 day approval turnaround any day if not already I would expect. -
Understand what you own here.
Not selling until all the News has been announced, next 8 weeks of Q4 will be very busy...& rewarding for all longs.
GLAH.
.
- Forums
- ASX - By Stock
- GTG
- Genetic Technologies Provides Update on COVID-19 Risk Test
Genetic Technologies Provides Update on COVID-19 Risk Test, page-4
Featured News
Add GTG (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.671M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
GTG (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online